November 8, 2018

Heart Attack Survivors, Talk to Your Doc About This Drug

Cholesterol Drug Lowers Risk in Heart Attack Survivors Forward to a friend | View Online
 
t.png p.png
8975842d-d31a-4ad4-95a9-bcce47223048.jpg
Cholesterol Drug Lowers Risk in Heart Attack Survivors
New England Journal of Medicine — In a large clinical trial involving patients who had recently experienced a heart attack, researchers found that the cholesterol-lowering medication alirocumab (Praluent) reduced the risk of additional heart problems and stroke.
Read More »
Cervical Cancer Risk: Are At-Home HPV Tests Reliable?
Obstetrics & Gynecology — Mail-in, at-home kits to test for high-risk human papillomavirus (HPV) infection can help improve cervical cancer screening, especially in women who are overdue for testing, according to a study.
Read More »
Singing May Lessen Parkinson's Symptoms, Study Shows
Science Daily — Data from a pilot study suggests singing may lessen the effects of stress, improve mood, and have a beneficial effect on motor symptoms in Parkinson's patients.
Read More »
Work Stress and Your Heart
Berkeley Wellness — People with high-strain jobs are at increased risk for atrial fibrillation (a-fib), a common heart rhythm disorder that can lead to strokes, according to a Swedish study.
Read More »
Acid Reflux, Heartburn, GERD: What's the Difference?
HealthCentral — These terms are often used interchangeably, but are they really the same thing? Here's what you should know about these GI issues.
Read More »
imp?s=187247&sz=300x250&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=a303e47c30
imp?s=187248&sz=1x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=a303e47c30 imp?s=187249&sz=1x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=a303e47c30
imp?s=95371&sz=116x15&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=a303e47c30 imp?s=96074&sz=69x15&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=a303e47c30
More from Health Central
The Remedy Health Network
Berkeley Wellness science-backed, expert-vetted health and wellness advice

The Body current and complete coverage for the HIV/AIDS community
Newsletter Options
This email was sent to clrmyers6@gmail.com

We're happy to help you unsubscribe or manage your email preferences.

If this email was forwarded to you by another email recipient and you would like to subscribe, click here.

Ensure you receive this newsletter by adding us to your safe sender's list.

You can also forward this newsletter to a friend.
t.png p.png
imp?s=124359000&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=a303e47c30 imp?s=124359001&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=a303e47c30 imp?s=124359002&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=a303e47c30 imp?s=124359003&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=a303e47c30 imp?s=124359004&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=a303e47c30 imp?s=124359005&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=a303e47c30 imp?s=124359006&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=a303e47c30 imp?s=124359007&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=a303e47c30 imp?s=124359008&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=a303e47c30 imp?s=124359009&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=a303e47c30 imp?s=124359010&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=a303e47c30 imp?s=124359011&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=a303e47c30 imp?s=124359012&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=a303e47c30 imp?s=124359013&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=a303e47c30 imp?s=124359014&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=a303e47c30 imp?s=124359015&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=a303e47c30 imp?s=124359016&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=a303e47c30 imp?s=124359017&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=a303e47c30 imp?s=124359018&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=a303e47c30 imp?s=124359019&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=a303e47c30

No comments:

Post a Comment